diphtheria/tetanus/pertussis/hemophilus influenzae type b conjugate vaccine (Zydus-Cadila/Cadila Healthcare)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namediphtheria/tetanus/pertussis/hemophilus influenzae type b conjugate vaccine (Zydus-Cadila/Cadila Healthcare)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZydus Cadila
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZydus CadilaZydus Lifesciences Ltd
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A